Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Clearside Biomedical Inc CLSD

Healthcare
Clearside Biomedical, Inc. is a biopharmaceutical company focused on the delivery of therapies to the back of the eye through the suprachoroidal space (SCS). The Company's SCS injection platform, utilizing its patented SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a variety of therapies to the macula, retina, or... see more

Recent & Breaking News (NDAQ:CLSD)

Clearside Biomedical to Present at the Needham Virtual Healthcare Conference

GlobeNewswire April 8, 2020

Clearside Biomedical Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

GlobeNewswire March 11, 2020

Clearside Biomedical Appoints Dr. George Lasezkay as President and Chief Executive Officer

GlobeNewswire March 11, 2020

Clearside Biomedical Announces License Agreement with Arctic Vision for XIPERE(TM) (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China and South Korea

GlobeNewswire March 11, 2020

Clearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020

GlobeNewswire February 27, 2020

Clearside Biomedical to Present at Two Upcoming Investor Conferences in March 2020

GlobeNewswire February 26, 2020

Clearside Biomedical Pipeline Highlighted in Oral Presentations at the Annual Angiogenesis and Macula Society Meetings

GlobeNewswire February 25, 2020

Clearside Biomedical Announces Presentations to be Given at Angiogenesis and Macula Society Conferences

GlobeNewswire February 5, 2020

Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3 Data ON XIPERETM (triamcinolone acetonide suprachoroidal injectable suspension) in Ophthalmology

PR Newswire January 28, 2020

Clearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 6, 2020

Clearside Biomedical to Present at the Stifel 2019 Healthcare Conference

GlobeNewswire November 13, 2019

Clearside Biomedical Announces Third Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire November 6, 2019

Clearside Biomedical to Report Third Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, November 6, 2019

GlobeNewswire October 30, 2019

Clearside Biomedical Announces Option Exercise by REGENXBIO for Global License for Use of SCS Microinjector(TM) in AAV Gene Therapy Delivery

GlobeNewswire October 30, 2019

Bausch Health Licenses Clearside Biomedical's XIPERE(TM) (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis

PR Newswire October 23, 2019

Clearside Biomedical Suprachoroidal Injection Platform Featured in Multiple Presentations at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting

GlobeNewswire October 17, 2019

Clearside Biomedical Announces Multiple Presentations to be Given at the American Academy of Ophthalmology (AAO) 2019 Annual Meeting

GlobeNewswire October 3, 2019

Clearside Biomedical Featured at Multiple European Scientific Retinal Congresses

GlobeNewswire September 19, 2019

REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314

PR Newswire September 4, 2019

Clearside Biomedical to Present at the Janney Montgomery Scott Healthcare Conference

GlobeNewswire September 3, 2019